Bovine spongiform encephalopathy

Journal of the American Veterinary Medical Association

Volumn 234, Issue 1, 2009, Pages 59-72

  Harman, Jane L ^a,c   Silva, Christopher J ^b  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b WESTERN REGIONAL RESEARCH CENTER   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; MINERAL; PRION PROTEIN;

AGE; ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; BONE MEAL; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EPIDEMIC; GENETIC PREDISPOSITION; HUMAN; PATHOLOGY; REVIEW; RISK FACTOR; ZOONOSIS;

AGE FACTORS; ANIMAL FEED; ANIMALS; BIOLOGICAL PRODUCTS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; DISEASE OUTBREAKS; ENCEPHALOPATHY, BOVINE SPONGIFORM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MINERALS; PRPSC PROTEINS; RISK FACTORS; ZOONOSES;

BOVINAE;

EID: 58249117622     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.234.1.59     Document Type: Review

References (285)

1. Wells GA, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987;121:419-420.
2. World Organisation for Animal Health (OIE). Number of reported cases of bovine spongiform encephalopathy (BSE) in farmed cattle worldwide. September 16, 2008. Available at: www.oie.int/eng/info/en-esbmonde.htm. Accessed Nov 30, 2008.
3. Donnelly CA, Ferguson NM, Ghani AC, et al. Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels. Proc Biol Sci 2002;269:2179-2190.
4. Aguzzi A. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J Neurochem 2006;97:1726-1739.
5. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-144.
6. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998;95:13363-13383.
7. Cuille J, Chelle PL. La maladie dite tremblante du mouton estelle inoculable? C R Acad Sci 1936;26:1552-1554.
8. Pattison IH, Hoare MN, Jebbett JN, et al. Spread of scrapie to sheep and goats by oral dosing with foetal membranes from scrapie-affected sheep. Vet Rec 1972;90:465-468.
9. Pattison IH, Hoare MN, Jebbett JN, et al. Further observations on the production of scrapie in sheep by oral dosing with foetal membranes from scrapie-affected sheep. Br Vet J 1974;130:lxv-lxvii.
10. Gordon WS. Advances in veterinary research: louping-ill tickborne fever and scrapie. Vet Res 1946;58:516-520.
11. Marsh RF, Hanson RP. On the origin of transmissible mink encephalopathy In: Prusiner SB, Hadlow WJ, eds. Slow transmissible diseases of the nervous system. New York: Academic Press Inc, 1979;455-460.
12. Gajdusek DC. Unconventional viruses and the origin and disappearance of kuru. Science 1977;197:943-960.
13. Dawson M, Wells GA, Parker BN. Preliminary evidence of the experimental transmissibility of bovine spongiform encephalopathy to cattle. Vet Rec 1990;126:112-113.
14. Dawson M, Wells GAH, Parker BNJ, et al. Transmission studies of BSE in cattle, hamsters, pigs and domestic fowl. In: Bradley R, Savey M, Marchant B, eds. Sub-acute spongiform encephalopathies. Proceedings of a seminar in the CEC Agricultural Research Programme, held in Brussels, 12-14 November, 1990. Sponsored by the Commission of the European Communities, Directorate-General for Agriculture, Division for the Coordination of Agricultural Research. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1991;25-32.
15. Fraser H, McConnell I, Wells GA, et al. Transmission of bovine spongiform encephalopathy to mice. Vet Rec 1988;123:472.
16. Detwiler LA, Baylis M. The epidemiology of scrapie. Rev Sci Tech 2003;22:121-143.
17. Marsh RF, Hadlow WJ. Transmissible mink encephalopathy. Rev Sci Tech 1992;11:539-550.
18. Williams ES. Chronic wasting disease. Vet Pathol 2005;42:530-549.
19. Gajdusek DC, Zigas V. Kuru; clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea. Am J Med 1959;26:442-469.
20. Belay ED. Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol 1999;53:283-314.
21. Sy MS, Gambetti P, Wong BS. Human prion diseases. Med Clin North Am 2002;86:551-571.
22. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
23. Lasmezas CI, Deslys JP, Demaimay R, et al. BSE transmission to macaques. Nature 1996;381:743-744.
24. Wilesmith JW, Wells GA, Cranwell MP, et al. Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 1988;123:638-644.
25. Wilesmith JW, Hoinville LJ, Ryan JB, et al. Bovine spongiform encephalopathy: aspects of the clinical picture and analyses of possible changes 1986-1990. Vet Rec 1992;130:197-201.
26. Bradley R. Bovine spongiform encephalopathy (BSE): the current situation and research. Eur J Epidemiol 1991;7:532-544.
27. Braun U, Schicker E, Hornlimann B. Diagnostic reliability of clinical signs in cows with suspected bovine spongiform encephalopathy. Vet Rec 1998;143:101-105.
28. Veterinary Laboratories Agency Web site. TSE video clips (clinical signs). Cattle video clips. Available at: www.defra.gov.uk/vla/science/sci-tse- rl-video.htm. Accessed Nov 30, 2008.
29. Winter MH, Aldridge BM, Scott PR, et al. Occurrence of 14 cases of bovine spongiform encephalopathy in a closed dairy herd. Br Vet J 1989;145:191-194.
30. Scott PR, Aldridge BM, Clarke M, et al. Cerebrospinal fluid studies in normal cows and cases of bovine spongiform encephalopathy. Br Vet J 1990;146:88-90.
31. Breslin P, McElroy M, Bassett H, et al. Vacuolar lesion profile of BSE in the Republic of Ireland. Vet Rec 2006;159:889-890.
32. Simmons MM, Harris P, Jeffrey M, et al. BSE in Great Britain: consistency of the neurohistopathological findings in two random annual samples of clinically suspect cases. Vet Rec 1996;138:175-177.
33. Jeffrey M, Gonzalez L. Pathology and pathogenesis of bovine spongiform encephalopathy and scrapie. Curr Top Microbiol Immunol 2004;284:65-97.
34. Wells GA, Wilesmith JW. The neuropathology and epidemiology of bovine spongiform encephalopathy. Brain Pathol 1995;5:91-103.
35. Wells GA, Hancock RD, Cooley WA, et al. Bovine spongiform encephalopathy: diagnostic significance of vacuolar changes in selected nuclei of the medulla oblongata. Vet Rec 1989;125:521-524.
36. Basler K, Oesch B, Scott M, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986;46:417-428.
37. Chesebro B, Race R, Wehrly K, et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 1985;315:331-333.
38. Oesch B, Westaway D, Walchli M, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985;40:735-746.
39. Oidtmann B, Simon D, Holtkamp N, et al. Identification of cDNAs from Japanese pufferfish (Fugu rubripes) and Atlantic salmon (Salmo salar) coding for homologues to tetrapod prion proteins. FEBS Lett 2003;538:96-100.
40. Simonic T, Duga S, Strumbo B, et al. cDNA cloning of turtle prion protein. FEBS Lett 2000;469:33-38.
41. Strumbo B, Ronchi S, Bolis LC, et al. Molecular cloning of the cDNA coding for Xenopus laevis prion protein. FEBS Lett 2001;508:170-174.
42. Gabriel JM, Oesch B, Kretzschmar H, et al. Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci U S A 1992;89:9097-9101.
43. Bendheim PE, Brown HR, Rudelli RD, et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 1992;42:149-156.
44. Ford MJ, Burton LJ, Morris RJ, et al. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002;113:177-192.
45. Linden R, Martins VR, Prado MA, et al. Physiology of the prion protein. Physiol Rev 2008;88:673-728.
46. Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986;315:997-1003.
47. Baldwin M, Stahl N, Hecker R, et al. Glycosylinositol phospholipid anchors of prion proteins. In: Prusiner SB, Collinge J, Powell J, et al, eds. Prion diseases of humans and animals. New York, NY: Ellis Horwood, 1992;380-397.
48. Rudd PM, Endo T, Colominas C, et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 1999;96:13044-13049.
49. Stahl N, Baldwin M, Teplow DB, et al. Cataloging post-translational modifications of the scrapie prion protein by mass spectrometry. In: Prusiner SB, Collinge J, Powell J, et al, eds. Prion diseases of humans and animals. New York: Ellis Horwood, 1992;361-379.
50. Cohen FE, Pan KM, Huang Z, et al. Structural clues to prion replication. Science 1994;264:530-531.
51. Eigen M. Prionics or the kinetic basis of prion diseases. Biophys Chem 1996;63:A1-A18.
52. Harper JD, Lansbury PT Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997;66:385-407.
53. Bessen RA, Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992;73:329-334.
54. Pattison IH, Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 1961;71:101-109.
55. Safar J, Wille H, Itri V, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998;4:1157-1165.
56. Peretz D, Scott MR, Groth D, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 2001;10:854-863.
57. Aguzzi A. Understanding the diversity of prions. Nat Cell Biol 2004;6:290-292.
58. Kimberlin RH, Cole S, Walker CA. Transmissible mink encephalopathy (TME) in Chinese hamsters: identification of two strains of TME and comparisons with scrapie. Neuropathol Appl Neurobiol 1986;12:197-206.
59. Kimberlin RH, Cole S, Walker CA. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol 1987;68:1875-1881.
60. Pattison IH. Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. In: Gajdusek CJ, Gibbs CJ, Alpers MP, eds. Slow, latent, and temperate virus infections. Washington, DC: US Government Printing Office, 1965;249-257.
61. Castilla J, Gutierrez-Adan A, Brun A, et al. Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein. J Neurosci 2004;24:5063-5069.
62. Hill AF, Collinge J. Prion strains and species barriers. Contrib Microbiol 2004;11:33-49.
63. Hill AF, Joiner S, Linehan J, et al. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A 2000;97:10248-10253.
64. Race R, Chesebro B. Scrapie infectivity found in resistant species. Nature 1998;392:770.
65. Wadsworth JD, Asante EA, Desbruslais M, et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 2004;306:1793-1796.
66. Pattison IH, Gordon WS, Millson GC. Experimental production of scrapie in goats. J Comp Pathol 1959;69:300-312.
67. Pattison IH, Jones KM. Modification of a strain of mouse-adapted scrapie by passage through rats. Res Vet Sci 1968;9:408-410.
68. Brown P, Bradley R, Detwiler L, et al. Transmissible spongiform encephalopathy as a zoonotic disease. International Life Sciences Institute (ILSI) Europe report series. Brussels: ILSI Press, 2003. Available at: europe.ilsi.org/NR/rdonlyres/CE379ACA-33D7-4BA1-A94C-75D12E730BB6/0/TSE.pdf. Accessed Nov 30, 2008.
69. Horn G, Bobrow M, Bruce ME, et al. Review of the origin of BSE. London: Stationery Office, 2001;1-66. Available at: www.defra.gov.uk/animalh/ bse/publications/bseorigin.pdf. Accessed Nov 30, 2008.
70. Konoid T, Lee YH, Stack MJ, et al. Different prion disease phenotypes result from inoculation of cattle with two temporally separated sources of sheep scrapie from Great Britain. BMC Vet Res 2006;2:31.
71. Foster JD, Hope J, McConnell I, et al. Transmission of bovine spongiform encephalopathy to sheep, goats, and mice. Ann N Y Acad Sci 1994;724:300-303.
72. Foster JD, Hope J, Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Rec 1993;133:339-341.
73. Fraser H, Foster J. Transmission to mice, sheep and goats and bioassay of bovine tissues. In: Bradley R, Marchant B, ed. Transmissible Spongiform Encephalopathy. A consultation on BSE with the Scientific Veterinary Committee of the Commission of the European Communities held in Brussels, 14-15 September 1993. Brussels: European Commission Agriculture, 1994;145-159.
74. Bruce ME, Boyle A, Cousens S, et al. Strain characterization of natural sheep scrapie and comparison with BSE. J Gen Virol 2002;83:695-704.
75. Cutlip RC, Miller JM, Race RE, et al. Intracerebral transmission of scrapie to cattle. J Infect Dis 1994;169:814-820.
76. Robinson MM, Hadlow WJ, Knowles DP, et al. Experimental infection of cattle with the agents of transmissible mink encephalopathy and scrapie. J Comp Pathol 1995;113:241-251.
77. Cutlip RC, Miller JM, Hamir AN, et al. Resistance of cattle to scrapie by the oral route. Can J Vet Res 2001;65:131-132.
78. Beringue V, Andreoletti O, Le Dur A, et al. A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission. J Neurosci 2007;27:6965-6971.
79. Capobianco R, Casalone C, Suardi S, et al. Conversion of the BASE prion strain into the BSE strain: the origin of BSE? PLoS Pathog [serial online]. 2007;3:e31. Available at: www.plospathogens.org/home.action. Accessed Nov 4, 2008.
80. Colchester AC, Colchester NT. The origin of bovine spongiform encephalopathy: the human prion disease hypothesis. Lancet 2005;366:856-861.
81. Scott MR, Peretz D, Nguyen HO, et al. Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol 2005;79:5259-5271.
82. Stack MJ, Balachandran A, Chaplin M, et al. The first Canadian indigenous case of bovine spongiform encephalopathy (BSE) has molecular characteristics for prion protein that are simitar to those of BSE in the United Kingdom but differ from those of chronic wasting disease in captive elk and deer. Can Vet J 2004;45:825-830.
83. Hamir AN, Miller JM, Kunkle RA, et al. Susceptibility of cattle to first-passage intracerebral inoculation with chronic wasting disease agent from white-tailed deer. Vet Pathol 2007;44:487-493.
84. Hamir AN, Kunkle RA, Miller JM, et al. Experimental second passage of chronic wasting disease (CWD(mule deer)) agent to cattle. J Comp Pathol 2006;134:63-69.
85. Hamir AN, Kunkle RA, Cutlip RC, et al. Experimental transmission of chronic wasting disease agent from mule deer to cattle by the intracerebral route. J Vet Diagn Invest 2005;17:276-281.
86. Hamir AN, Cutlip RC, Miller JM, et al. Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle. J Vet Diagn Invest 2001;13:91-96.
87. Gould DH, Voss JL, Miller MW, et al. Survey of cattle in northeast Colorado for evidence of chronic wasting disease: geographical and high-risk targeted sample. J Vet Diagn Invest 2003;15:274-277.
88. Robinson MM. Experimental infections of cattle and mink with the agents of transmissible mink encephalopathy, scrapie, and bovine spongiform encephalopathy. In: Gibbs CJ, ed. Serono symposia USA. Bovine spongiform encephalopathy: the BSE dilemma. New York: Springer-Verlag, 1996;108-113.
89. Donnelly CA, Ferguson NM, Ghani AC, et al. The epidemiology of BSE in cattle herds in Great Britain. I. Epidemiological processes, demography of cattle and approaches to control by culling. Philos Trans R Soc Lond B Biol Sci 1997;352:781-801.
90. Hoinville LJ, Wilesmith JW, Richards MS. An investigation of risk factors for cases of bovine spongiform encephalopathy born after the introduction of the 'feed ban.' Vet Rec 1995;136:312-318.
91. Her Majesty's Stationery Office. The bovine spongiform encephalopathy order 1988. Statutory instrument 1988 No. 1039. London: Her Majesty's Stationery Office, 1988. Available at: www.opsi.gov.uk/si/si1988/Uksi-19881039- en-1.htm. Accessed Nov 30, 2008.
92. Veterinary Laboratories Agency. TSE surveillance statistics. Cattle. Age and related statistics. Confirmed cases of BSE born after 18 July 1988. September 1, 2008. Available at: www.defra.gov.uk/vla/science/docs/sci-tse- stats-age.pdf. Accessed Nov 30, 2008.
93. Stevenson MA, Morris RS, Lawson AB, et al. Area-level risks for BSE in British cattle before and after the July 1988 meat and bone meal feed ban. Prev Vet Med 2005;69:129-144.
94. Her Majesty's Stationary Office. The bovine spongiform encephalopathy order 1996. Statutory instrument 1996 No. 2007. London: Her Majesty's Stationary Office, 1996. Available at: www.opsi.gov.uk/SI/si1996/Uksi-19962007- en-1.htm. Accessed Nov 30, 2008.
95. Veterinary Laboratories Agency. TSE surveillance statistics. Cattle. Age and related statistics. Age at clinical onset in years by birth cohort. September 1, 2008. Available at: www.defra.gov.uk/vla/science/docs/sci-tse- stats-age.pdf. Accessed Nov 30, 2008.
96. Veterinary Laboratories Agency. TSE surveillance statistics. Cattle. General statistics on BSE cases in Great Britain. September 1, 2008. Available at: www.defra.gov.uk/vla/science/docs/sci-tse-stats-gen.pdf. Accessed Nov 30, 2008.
97. Veterinary Laboratories Agency. TSE surveillance statistics. Cattle. Age and related statistics. Confirmed cases of BSE in United Kingdom by year of birth where known. September 1, 2008. Available at: www.defra.gov.uk/vla/ science/docs/sci-tse-stats-age.pdf. Accessed Nov 30, 2008.
98. Hill W. Review of the evidence for the occurrence of 'BARB' BSE cases in cattle. Available at: www.defra.gov.uk/animalh/bse/pdf/hillreport.pdf. Accessed Nov 30, 2008.
99. Gibbens N. Link between feed bins and BSE cases born after July 1996. Vet Rec 2005;157:782-783.
100. Lasmezas CI, Comoy E, Hawkins S, et al. Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet 2005;365:781-783.
101. Wells GA, Konold T, Arnold ME, et al. Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle. J Gen Virol 2007;88:1363-1373.
102. Donnelly CA, Ferguson NM, Ghani AC, et al. Analysis of damcalf pairs of BSE cases: confirmation of a maternal risk enhancement. Proc Biol Sci 1997;264:1647-1656.
103. Wilesmith JW, Wells GA, Ryan JB, et al. A cohort study to examine maternally-associated risk factors for bovine spongiform encephalopathy. Vet Rec 1997;141:239-243.
104. Bradley R. Experimental transmission of bovine spongiform encephalopathy. In: Courl L, Dodet B, eds. Transmissible sub-acute spongiform encephalopathies. Paris: Elsevier, 1996;51-56.
105. Buschmann A, Groschup MH. Highly bovine spongiform encephalopathy- sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J Infect Dis 2005;192:934-942.
106. Everest SJ, Thorne LT, Hawthorn JA, et al. No abnormal prion protein detected in the milk of cattle infected with the bovine spongiform encephalopathy agent. J Gen Virol 2006;87:2433-2441.
107. Middleton DJ, Barlow RM. Failure to transmit bovine spongiform encephalopathy to mice by feeding them with extraneural tissues of affected cattle. Vet Rec 1993;132:545-547.
108. Taylor DM, Ferguson CE, Bostock CJ, et al. Absence of disease in mice receiving milk from cows with bovine spongiform encephalopathy. Vet Rec 1995;136:592.
109. Tyshenko MG. Bovine spongiform encephalopathy and the safety of milk from Canadian dairy cattle. Vet Rec 2007;160:215-218.
110. Wrathall AE, Brown KF, Sayers AR, et al. Studies of embryo transfer from cattle clinically affected by bovine spongiform encephalopathy (BSE). Vet Rec 2002;150:365-378.
111. Spongiform Encephalopathy Advisory Committee. Epidemiological update on BARB BSE cases. SEAC 80/4. London: Spongiform Encephalopathy Advisory Committee, 2004. Available at: www.seac.gov.uk/papers/seac80-4.pdf. Accessed Nov 30, 2008.
112. Department for Environment, Food and Rural Affairs. The exposure of British sheep and cattle to mites. SE1828. London: Department for Environment, Food and Rural Affairs. Available at: randd.defra.gov.uk/Document. aspx?Document=SE1828-1174-FRP.doc. Accessed Nov 30, 2008.
113. Gale P, Stanfield G. Towards a quantitative risk assessment for BSE in sewage sludge. J Appl Microbiol 2001;91:563-569.
114. Bateman D, Hilton D, Love S, et al. Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet 1995;346:1155-1156.
115. Britton TC, al-Sarraj S, Shaw C, et al. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet 1995;346:1155.
116. Chazot G, Broussolle E, Lapras C, et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996;347:1181.
117. Murray K, Ritchie DL, Bruce M, et al. Sporadic Creutzfeldt-Jakob disease in two adolescents. J Neurol Neurosurg Psychiatry 2007;79:14-18.
118. Collinge J, Sidle KC, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-690.
119. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
120. Matthews WB, Will RG. Creutzfeldt-Jakob disease in a lifelong vegetarian. Lancet 1981;2:937.
121. The European and Allied Countries Collaborative Study Group of CJD (EUROCJD). Total cases of CJD/GSS (deaths). Available at: www.eurocjd.ed.ac.uk/ allcjd.htm. Accessed Nov 30, 2008.
122. Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005;64:1586-1591.
123. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveill 2007;12:E070118.070114.
124. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-421.
125. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-529.
126. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and premortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368:2061-2067.
127. New case of transfusion-associated vCJD in the United Kingdom. Euro Surveill 2006;11:E060209.060202.
128. Bacchetti P. Age and variant Creutzfeldt-Jakob disease. Emerg Infect Dis 2003;9:1611-1612.
129. Boelle PY, Cesbron JY, Valleron AJ. Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect Dis 2004;4:26.
130. Heisey DM, Joly DO. Age and transmissible spongiform encephalopathies. Emerg Infect Dis 2004;10:1164-1165.
131. Mead S. Prion disease genetics. Eur J Hum Genet 2006;14:273-281.
132. Gajdusek DC, Gibbs CJ, Alpers M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 1966;209:794-796.
133. Cervenakova L, Goldfarb LG, Garruto R, et al. Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 1998;95:13239-13241.
134. CDC. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep 1987;36:49-50, 55.
135. Koch TK, Berg BO, De Armond SJ, et al. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med 1985;313:731-733.
136. Duffy P, Wolf J, Collins G, et al. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-693.
137. Belay ED, Schonberger LB. The public health impact of prion diseases. Annu Rev Public Health 2005;26:191-212.
138. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-1081.
139. Brown P, Brandel JP, Preece M, et al. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006;67:389-393.
140. Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000;159:10-17.
141. Bruce ME, McConnell I, Will RG, et al. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001;358:208-209.
142. Glatzel M, Giger O, Seeger H, et al. Variant Creutzfeldt-Jakob disease: between lymphoid organs and brain. Trends Microbiol 2004;12:51-53.
143. Herzog C, Sales N, Etchegaray N, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004;363:422-428.
144. Hilton DA, Ghani AC, Conyers L, et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 2002;325:633-634.
145. Ironside JW, Bishop MT, Connolly K, et al. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 2006;332:1186-1188.
146. Bishop MT, Hart P, Aitchison L, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006;5:393-398.
147. Kirkwood JK, Cunningham AA. Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles. Vet Rec 1994;135:296-303.
148. Cunningham AA, Wells GA, Scott AC, et al. Transmissible spongiform encephalopathy in greater kudu (Tragelaphus strepsiceros). Vet Rec 1993;132:68.
149. Fleetwood AJ, Furley CW. Spongiform encephalopathy in an eland. Vet Rec 1990;126:408-409.
150. Jeffrey M, Wells GA. Spongiform encephalopathy in a nyala (Tragelaphus angasi). Vet Pathol 1988;25:398-399.
151. Kirkwood JK, Cunningham AA, Austin AR, et al. Spongiform encephalopathy in a greater kudu (Tragelaphus strepsiceros) introduced into an affected group. Vet Rec 1994;134:167-168.
152. Kirkwood JK, Cunningham AA, Wells GA, et al. Spongiform encephalopathy in a herd of greater kudu (Tragelaphus strepsiceros): epidemiological observations. Vet Rec 1993;133:360-364.
153. Kirkwood JK, Wells GA, Cunningham AA, et al. Scrapie-like encephalopathy in a greater kudu (Tragelaphus strepsiceros) which had not been fed ruminant-derived protein. Vet Rec 1992;130:365-367.
154. Kirkwood JK, Wells GA, Wilesmith JW, et al. Spongiform encephalopathy in an arabian oryx (Oryx leucoryx) and a greater kudu (Tragelaphus strepsiceros). Vet Rec 1990;127:418-420.
155. Seuberlich T, Botteron C, Wenker C, et al. Spongiform encephalopathy in a miniature zebu. Emerg Infect Dis 2006;12:1950-1953.
156. Matthews D, Cooke BC. The potential for transmissible spongiform encephalopathies in non-ruminant livestock and fish. Rev Sci Tech 2003;22:283-296.
157. Veterinary Laboratories Agency. TSE surveillance statistics. Exotic species and domestic cat surveillance statistics. Available at: www.defra.gov.uk/vla/science/docs/sci-tse-stats-exotic.pdf. Accessed Nov 30, 2008.
158. The TSE community reference laboratory strain typing expert group (STEG). Summary of the STEG opinion on three isolates (05-0825 and 06-0017 from France; 204163425 from Cyprus) referred to the group following the identification of unusual molecular profiles on discriminatory Western blot (as required in EU Regulation 36/2005.). MEMO/06/113. Brussels: European Union, 2006. Available at: europa.eu/rapid/pressReleasesAction.do?reference=MEMO/06/ 113&format=HTML&aged=0&language=EN&guiLanguage=fr. Accessed Nov 30, 2008.
159. Dustan BH, Spencer YI, Casalone C, et al. A histopathologic and immunohistochemical review of archived UK caprine scrapie cases. Vet Pathol 2008;45:443-454.
160. Eloit M, Adjou K, Coulpier M, et al. BSE agent signatures in a goat. Vet Rec 2005;156:523-524.
161. Baron T, Crozet C, Biacabe AG, et al. Molecular analysis of the protease-resistant prion protein in scrapie and bovine spongiform encephalopathy transmitted to ovine transgenic and wildtype mice. J Virol 2004;78:6243-6251.
162. Bellworthy SJ, Hawkins SA, Green RB, et al. Tissue distribution of bovine spongiform encephalopathy infectivity in Romney sheep up to the onset of clinical disease after oral challenge. Vet Rec 2005;156:197-202.
163. Gonzalez L, Martin S, Houston FE, et al. Phenotype of disease-associated PrP accumulation in the brain of bovine spongiform encephalopathy experimentally infected sheep. J Gen Virol 2005;86:827-838.
164. Wells GA, Hawkins SA, Austin AR, et al. Studies of the transmissibility of the agent of bovine spongiform encephalopathy to pigs. J Gen Virol 2003;84:1021-1031.
165. Ryder SJ, Hawkins SA, Dawson M, et al. The neuropathology of experimental bovine spongiform encephalopathy in the pig. J Comp Pathol 2000;122:131-143.
166. Dagleish MP, Martin S, Steele P, et al. Experimental transmission of bovine spongiform encephalopathy to European red deer (Cervus elaphus elaphus). BMC Vet Res 2008;4:17.
167. Vorberg I, Groschup MH, Pfaff E, et al. Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol 2003;77:2003-2009.
168. Pearson GR, Gruffydd-Jones TJ, Wyatt JM, et al. Feline spongiform encephalopathy. Vet Rec 1991;128:532.
169. Wyatt JM, Pearson GR, Smerdon TN, et al. Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats. Vet Rec 1991;129:233-236.
170. Baron T, Belli P, Madec JY, et al. Spongiform encephalopathy in an imported cheetah in France. Vet Rec 1997;141:270-271.
171. Peet RL, Curran JM. Spongiform encephalopathy in an imported cheetah (Acinonyx jubatus). Aust Vet J 1992;69:171.
172. Willoughby K, Kelly DF, Lyon DG, et al. Spongiform encephalopathy in a captive puma (Felis concolor). Vet Rec 1992;131:431-434.
173. Lysek DA, Schorn C, Nivon LG, et al. Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci U S A 2005;102:640-645.
174. Richt JA, Kunkle RA, Alt D, et al. Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States. J Vet Diagn Invest 2007;19:142-154.
175. De Bosschere H, Roels S, Vanopdenbosch E. Atypical case of bovine spongiform encephalopathy in an East-Flemish cow in Belgium. Int J Appl Res Vet Med 2004;2:52-54.
176. Biacabe AG, Laplanche JL, Ryder S, et al. Distinct molecular phenotypes in bovine prion diseases. EMBO Rep 2004;5:110-115.
177. Casalone C, Zanusso G, Acutis P, et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 2004;101:3065-3070.
178. Yamakawa Y, Hagiwara K, Nohtomi K, et al. Atypical proteinase K-resistant prion protein (PrPres) observed in an apparently healthy 23-month-old Holstein steer. Jpn J Infect Dis 2003;56:221-222.
179. Hagiwara K, Yamakawa Y, Sato Y, et al. Accumulation of monoglycosylated form-rich, plaque-forming PrP(Sc) in the second atypical bovine spongiform encephalopathy case in Japan. Jpn J Infect Dis 2007;60:305-308.
180. Polak MP, Zmudzinski JF, Jacobs JG, et al. Atypical status of bovine spongiform encephalopathy in Poland: a molecular typing study. Arch Virol 2007;153:69-79.
181. Terry LA, Jenkins R, Thorne L, et al. First case of H-type bovine spongiform encephalopathy identified in Great Britain. Vet Rec 2007;160:873-874.
182. Beringue V, Bencsik A, Le Dur A, et al. Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy. PLoS Pathog [serial online]. 2006;2:e112. Available at: www.plospathogens.org/ home.action. Accessed Nov 4, 2008.
183. Buschmann A, Gretzschel A, Biacabe AG, et al. Atypical BSE in Germany - proof of transmissibility and biochemical characterization. Vet Microbiol 2006;117:103-116.
184. Gavier-Widen D, Noremark M, Langeveld JP, et al. Bovine spongiform encephalopathy in Sweden: an H-type variant. J Vet Diagn Invest 2008;20:2-10.
185. Department of Health and Human Services, CDC. BSE (bovine spongiform encephalopathy, or mad cow disease). Available at: www.cdc.gov/ncidod/dvrd/bse/. Accessed Nov 30, 2008.
186. Bruce M, Chree A, McConnell I, et al. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci 1994;343:405-411.
187. Fraser H, Bruce ME, Chree A, et al. Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol 1992;73:1891-1897.
188. Jacobs JG, Langeveld JP, Biacabe AG, et al. Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe. J Clin Microbiol 2007;45:1821-1829.
189. Lombardi G, Casalone C, D'Angelo A, et al. Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes. PLoS Pathog [serial online]. 2008;4:e1000075. Available at: www.plospathogens.org/home. action. Accessed Nov 4, 2008.
190. Comoy EE, Casalone C, Lescoutra-Etchegaray N, et al. Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS ONE [serial online]. 2008;3:e3017. Available at: www.plosone.org/home.action. Accessed Nov 4, 2008.
191. Kong Q, Zheng M, Casalone C, et al. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol 2008;82:3697-3701.
192. Brown P, McShane LM, Zanusso G, et al. On the question of sporadic or atypical bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Emerg Infect Dis 2006;12:1816-1821.
193. Biacabe AG, Morignat E, Vulin J, et al. Atypical bovine spongiform encephalopathies, France, 2001-2007. Emerg Infect Dis 2008;14:298-300.
194. Brunelle BW, Hamir AN, Baron T, et al. Polymorphisms of the prion gene promoter region that influence classical BSE susceptibility are not applicable to other transmissible spongiform encephalopathies in cattle. J Anim Sci 2007;85:3142-3147.
195. Heaton MP, Keele JW, Harhay GP, et al. Prevalence of the prion protein gene E211K variant in US cattle. BMC Vet Res 2008;4:25.
196. Nicholson EM, Brunelle BW, Richt JA, et al. Identification of a heritable polymorphism in bovine PRNP associated with genetic transmissible spongiform encephalopathy: evidence of heritable BSE. PLoS ONE [serial online]. 2008;3:e2912. Available al: www.plosone.org/home.action. Accessed Nov 4, 2008.
197. Richt JA, Hall SM. BSE case associated with prion protein gene mutation. PLoS Pathog [serial online]. 2008;4:e1000156. Available at: www.plospathogens.org/home.action. Accessed Nov 4, 2008.
198. Clawson ML, Richt JA, Baron T, et al. Association of a bovine prion gene haplotype with atypical BSE. PLoS ONE [serial online]. 2008;3:e1830. Available at: www.plosone.org/home.action. Accessed Nov 4, 2008.
199. Marsh RF, Bessen RA, Lehmann S, et al. Epidemiological and experimental studies on a new incident of transmissible mink encephalopathy. J Gen Virol 1991;72:589-594.
200. Robinson MM. An assessment of transmissible mink encephalopathy as an indicator of bovine scrapie in US cattle. In: Gibbs CJ, ed. Serono symposia USA. Bovine spongiform encephalopathy: the BSE dilemma. New York: Springer-Verlag, 1996;97-107.
201. Robinson MM, Hadlow WJ, Huff TP, et al. Experimental infection of mink with bovine spongiform encephalopathy. J Gen Virol 1994;75:2151-2155.
202. Baron T, Bencsik A, Biacabe AG, et al. Phenotypic similarity of transmissible mink encephalopathy in cattle and L-type bovine spongiform encephalopathy in a mouse model. Emerg Infect Dis 2007;13:1887-1894.
203. Anderson RM, Donnelly CA, Ferguson NM, et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996;382:779-788.
204. Ferguson NM, Donnelly CA, Woolhouse ME, et al. The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics. Philos Trans R Soc Lond B Biol Sci 1997;352:803-838.
205. Supervie V, Costagliola D. The unrecognised French BSE epidemic. Vet Res 2004;35:349-362.
206. Nicholson EM, Richt JA, Rasmussen MA, et al. Exposure of sheep scrapie brain homogenate to rumen-simulating conditions does not result in a reduction of PrP(Sc) levels. Lett Appl Microbiol 2007;44:631-636.
207. Scherbel C, Pichner R, Groschup MH, et al. Infectivily of scrapie prion protein (PrP(Sc)) following in vitro digestion with bovine gastrointestinal microbiota. Zoonoses Public Health 2007;54:185-190.
208. Wilesmith JW, Ryan JB, Hueston WD. Bovine spongiform encephalopathy: case-control studies of calf feeding practices and meat and bonemeal inclusion in proprietary concentrates. Res Vet Sci 1992;52:325-331.
209. Hills D, Schlaepfer J, Comincini S, et al. Sequence variation in the bovine and ovine PRNP genes. Anim Genet 2003;34:183-190.
210. Seabury CM, Honeycutt RL, Rooney AP, et al. Prion protein gene (PRNP) variants and evidence for strong purifying selection in functionally important regions of bovine exon 3. Proc Natl Acad Sci U S A 2004;101:15142-15147.
211. Sander P, Hamann H, Pfeiffer I, et al. Analysis of sequence variability of the bovine prion protein gene (PRNP) in German cattle breeds. Neurogenetics 2004;5:19-25.
212. Curnow RN, Hau CM. The incidence of bovine spongiform encephalopathy in the progeny of affected sires and dams. Vet Rec 1996;138:407-408.
213. Hau CM, Curnow RN. Separating the environmental and genetic factors that may be causes of bovine spongiform encephalopathy. Philos Trans R Soc Lond B Biol Sci 1996;351:913-920.
214. Hunter N, Goldmann W, Smith G, et al. Frequencies of PrP gene variants in healthy cattle and cattle with BSE in Scotland. Vet Rec 1994;135:400-403.
215. Wijeratne WV, Curnow RN. A study of the inheritance of susceptibility to bovine spongiform encephalopathy. Vet Rec 1990;126:5-8.
216. Wijeratne WV, Curnow RN. Inheritance of BSE. Vet Rec 1990;126:176.
217. Saunders GC, Griffiths PC, Cawthraw S, et al. Polymorphisms of the prion protein gene coding region in born-after-the-reinforced-ban (BARB) bovine spongiform encephalopathy cattle in Great Britain. J Gen Virol 2007;88:1374-1378.
218. Haase B, Doherr MG, Seuberlich T, et al. PRNP promoter polymorphisms are associated with BSE susceptibility in Swiss and German cattle. BMC Genet [serial online]. 2007;8:15. Available at: www.biomedcentral.com/bmcgenet/. Accessed Nov 4, 2008.
219. Juling K, Schwarzenbacher H, Williams JL, et al. A major genetic component of BSE susceptibility. BMC Biol [serial online]. 2006;4:33. Available at: www.biomedcentral.com/bmcbiol/. Accessed Nov 4, 2008.
220. Sander P, Hamann H, Drogemuller C, et al. Bovine prion protein gene (PRNP) promoter polymorphisms modulate PRNP expression and may be responsible for differences in bovine spongiform encephalopathy susceptibility. J Biol Chem 2005;280:37408-37414.
221. World Organisation for Animal Health (OIE). Chapter 2.3.13: bovine spongiform encephalopathy. In: Manual of diagnostic tests and vaccines for terrestrial animals. Paris: World Organisation for Animal Health (OIE), 2004. Available at: www.oie.int/eng/normes/mmanual/A-00064.htm. Accessed Nov 30, 2008.
222. Arnold ME, Wilesmith JW. Estimation of the age-dependent risk of infection to BSE of dairy cattle in Great Britain. Prev Vet Med 2004;66:35-47.
223. Espinosa JC, Morales M, Castilla J, et al. Progression of prion infectivity in asymptomatic cattle after oral bovine spongiform encephalopathy challenge. J Gen Virol 2007;88:1379-1383.
224. Hoffmann C, Ziegler U, Buschmann A, et al. Prions spread via the autonomic nervous system from the gut to the central nervous system in cattle incubating bovine spongiform encephalopathy. J Gen Virol 2007;88:1048-1055.
225. Kimura K, Haritani M. Distribution of accumulated prion protein in a cow with bovine spongiform encephalopathy. Vet Rec 2008;162:822-825.
226. European Commission Health and Consumer Protection Directorate-General Scientific Steering Committee. Update of the opinion on TSE infectivity distribution in ruminant tissues. Initially adopted on 10-11 January 2002 and amended on 7-8 November 2002 following the submission of (1) a risk assessment by the German Federal Ministry of Consumer Protection, Food and Agriculture and (2) new scientific advice regarding BSE infectivity distribution in tonsils. Brussels: European Commission, 2002. Available at: europa.eu.int/comm/food/fs/ sc/ssc/out296-en.pdf. Accessed Nov 30, 2008.
227. Wells GA, Hawkins SA, Green RB, et al. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 1998;142:103-106.
228. Terry LA, Marsh S, Ryder SJ, et al. Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet Rec 2003;152:387-392.
229. European Commission Health and Consumer Protection Directorate-General Scientific Steering Committee. Opinion on BSE risk of the bovine autonomic nervous system. Adopted by the Scientific Steering Committee at its meeting of 6-7 March 2003. Brussels: European Commission, 2003. Available at: europa.eu.int/comm/food/fs/sc/ssc/out318-en.pdf. Accessed Nov 30, 2008.
230. Iwata N, Sato Y, Higuchi Y, et al. Distribution of PrP(Sc) in cattle with bovine spongiform encephalopathy slaughtered at abattoirs in Japan. Jpn J Infect Dis 2006;59:100-107.
231. Masujin K, Matthews D, Wells GA, et al. Prions in the peripheral nerves of bovine spongiform encephalopathy-affected cattle. J Gen Virol 2007;88:1850-1858.
232. Cunningham AA, Kirkwood JK, Dawson M, et al. Bovine spongiform encephalopathy infectivity in greater kudu (Tragelaphus strepsiceros). Emerg Infect Dis 2004;10:1044-1049.
233. van Keulen LJ, Schreuder BE, Meloen RH, et al. Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie. J Clin Microbiol 1996;34:1228-1231.
234. van Keulen LJ, Vromans ME, van Zijderveld FG. Early and late pathogenesis of natural scrapie infection in sheep. APMIS 2002;110:23-32.
235. Williams ES, Miller MW. Chronic wasting disease in deer and elk in North America. Rev Sci Tech 2002;21:305-316.
236. Wells GA, Dawson M, Hawkins SA, et al. Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec 1994;135:40-41.
237. Wells GAH, Kretzschmer HA. Pathogenesis, tissue infectivity distribution and specified risk materials. In: Vossen P, Kreysa J, Goll M, eds. Overview of the BSE risk assessments of the European Commissions Scientific Steering Committee (SSC) and its TSE/BSE ad hoc group. Brussels: European Commission, 2003;75-84. Available at: ec.europa.eu/food/fs/sc/ssc/out364-en.pdf. Accessed Nov 30, 2008.
238. Brown P, Cervenakova L, McShane LM, et al. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999;39:1169-1178.
239. Cervenakova L, Yakovleva O, McKenzie C, et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003;43:1687-1694.
240. Kimberlin RH. Bovine spongiform encephalopathy and public health: some problems and solutions in assessing the risk. In: Court L, Dodet B, eds. 3rd International Symposium on Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, March 18-20, 1996, Paris. Amsterdam: Elsevier, 1996;487-502.
241. Wells GA, Hawkins SA, Green RB, et al. Limited detection of sternal bone marrow infectivity in the clinical phase of experimental bovine spongiform encephalopathy (BSE). Vet Rec 1999;144:292-294.
242. Safar JG, Scott M, Monaghan J, et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 2002;20:1147-1150.
243. Grassi J, Maillet S, Simon S, et al. Progress and limits of TSE diagnostic tools. Vet Res 2008;39:33.
244. Commission Regulation (EC) No 253/2006 of 14 February 2006 amending Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards rapid tests and measures for the eradication of TSEs in ovine and caprine animals. Off J Eur Union [serial online]. 2006;49:L 44/9-L 44/12. Available at: eur-lex.europa.eu/LexUriServ/site/en/oj/2006/1-044/1- 04420060215en00090012.pdf. Accessed Nov 30, 2008.
245. European Food Safety Authority. EFSA Scientific Report (2005) 48, 1-10 on the Evaluation of Two Rapid post mortem BSE Tests. Scientific Report of the European Food Safety Authority on the Evaluation of two Rapid post mortem BSE Tests. Question No EFSA-Q-2003-084. Adopted on 2 September 2005. Parma, Italy: European Food Safety Authority, 2005. Available at: www.efsa.eu.int/cs/ BlobServer/Scientific-Document/biohaz-sr-ej48-bsetests-fujirebioldl-en1.pdf? ssbinary=true. Accessed Nov 30, 2008.
246. Deslys JP, Comoy E, Hawkins S, et al. Screening slaughtered cattle for BSE. Nature 2001;409:476-478.
247. Philipp W, van Iwaarden P, Goll M, et al. The evaluation of 10 rapid post mortem tests for the diagnosis of transmissible spongiform encephalopathy in bovines. Geel, Belgium: European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, 2004. Available at: www.irmm.jrc.be/html/ activities/TSE-testing/ phaseIBSEtestevaluation2004globalreport.pdf. Accessed Nov 30, 2008.
248. Philipp W, Vodrazka P. The field trial of seven new rapid post mortem tests for the diagnosis of bovine spongiform encephalopathy in bovines. Geel, Belgium: European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, 2004. Available at: www.irmm.jrc.be/html/activities/ TSE-testing/GlobalreportphaseII.pdf. Accessed Nov 30, 2008.
249. Graber HU, Meyer RK, Fatzer R, et al. In situ hybridization and immunohistochemistry for prion protein (PrP) in bovine spongiform encephalopathy (BSE). Zentralbl Veterinarmed [A] 1995;42:453-459.
250. Katz JB, Shafer AL, Miller JM. Production of antiserum for the diagnosis of scrapie and bovine spongiform encephalopathy using a baculovirus-expressed prion protein antigen. J Vet Diagn Invest 1995;7:245-247.
251. Wells GA, Spencer YI, Haritani M. Configurations and topographic distribution of PrP in the central nervous system in bovine spongiform encephalopathy: an immunohistochemical study. Ann N Y Acad Sci 1994;724:350-352.
252. Beekes M, Baldauf E, Cassens S, et al. Western blot mapping of disease-specific amyloid in various animal species and humans with transmissible spongiform encephalopathies using a high-yield purification method. J Gen Virol 1995;76:2567-2576.
253. Farquhar CF, Somerville RA, Ritchie LA. Post-mortem immunodiagnosis of scrapie and bovine spongiform encephalopathy. J Virol Methods 1989;24:215-221.
254. Hope J, Reekie LJ, Hunter N, et al. Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature 1988;336:390-392.
255. Simon S, Nugier J, Morel N, et al. Rapid typing of transmissible spongiform encephalopathy strains with differential ELISA. Emerg Infect Dis 2008;14:608-616.
256. Monleon E, Monzon M, Hortells P, et al. Detection of PrP(sc) in samples presenting a very advanced degree of autolysis (BSE liquid state) by immunocytochemistry. J Histochem Cytochem 2003;51:15-18.
257. Wear A, Henderson K, Webster K, et al. A comparison of rapid bovine spongiform encephalopathy testing methods on autolyzed bovine brain tissue. J Vet Diagn Invest 2005;17:99-102.
258. Jones M, Peden A, Prowse C, et al. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrP(Sc). J Pathol 2007;213:21-26.
259. Kurt TD, Perrott MR, Wilusz CJ, et al. Efficient in vitro amplification of chronic wasting disease PrPRES. J Virol 2007;81:9605-9608.
260. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001;411:810-813.
261. Soto C, Anderes L, Suardi S, et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 2005;579:638-642.
262. Vilette D. Cell models of prion infection. Vet Res 2007;39:10.
263. Onisko BC, Silva CJ, Dynin I, et al. Sensitive, preclinical detection of prions in brain by nanospray liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2007;21:4023-4026.
264. Sigurdson CJ, Nilsson KP, Hornemann S, et al. Prion strain discrimination using luminescent conjugated polymers. Nat Methods 2007;4;1023-1030.
265. Tcherkasskaya O, Davidson EA, Schmerr MJ, et al. Conformational biosensor for diagnosis of prion diseases. Biotechnol Lett 2005;27:671-675.
266. Committee on Transmissible Spongiform Encephalopathies: Assessment of Relevant Science. Chapter 4. Diagnostics for transmissible spongiform encephalopathies In: Erdtmann R, Sivitz L, eds. Advancing prion science: guidance for the National Prion Research Program. Washington, DC: The National Academies Press, 2004;67-96.
267. Committee of the Inquiry. The BSE inquiry: the inquiry into BSE and vCJD in the United Kingdom. Evidence: materials. M-12 rendering. 12. Exports of meal of meat and meat offal; greaves. Available at: www.bseinquiry.gov.uk/files/mb/ mf2/tab12.pdf. Accessed Nov 30, 2008.
268. Doherr MG, Heim D, Fatzer R, et al. Targeted screening of high-risk cattle populations for BSE to augment mandatory reporting of clinical suspects. Prev Vet Med 2001;51:3-16.
269. Ducrot C, Roy P, Morignat E, et al. How the surveillance system may bias the results of analytical epidemiological studies on BSE: prevalence among dairy versus beef suckler cattle breeds in France. Vet Res 2003;34:185-192.
270. Cashman NR. Transmissible spongiform encephalopathies: vaccine issues. Dev Biol (Basel) 2001;106:455-459.
271. Center for Biologics Evaluation and Research, US FDA. CBER and FDA guidance on sourcing of bovine derived raw materials. Available at: www.fda.gov/CbER/bse/bse.htm#bsegde. Accessed Nov 30, 2008.
272. World Organisation for Animal Health (OIE). Recognition of the bovine spongiform encephalopathy status of member countries. Available at: www.oie.int/eng/info/en-statesb.htm?e1d6. Accessed Nov 30, 2008.
273. Taylor DM. Resistance of transmissible spongiform encephalopathy agents to decontamination. Contrib Microbiol 2004;11:136-145.
274. Peretz D, Supattapone S, Giles K, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 2006;80:322-331.
275. Taylor DM. Preventing accidental transmission of human transmissible spongiform encephalopathies. Br Med Bull 2003;66:293-303.
276. Taylor DM, Fernie K, McConnell I, et al. Observations on thermostable subpopulations of the unconventional agents that cause transmissible degenerative encephalopathies. Vet Microbiol 1998;64:33-38.
277. Brown P, Liberski PP, Wolff A, et al. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. J Infect Dis 1990;161:467-472.
278. Brown P, Rohwer RG, Green EM, et al. Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. J Infect Dis 1982;145:683-687.
279. Prusiner SB, Groth D, Serban A, et al. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sci U S A 1993;90:2793-2797.
280. Brown P, Rau EH, Lemieux P, et al. Infectivity studies of both ash and air emissions from simulated incineration of scrapie-contaminated tissues. Environ Sci Technol 2004;38:6155-6160.
281. Ernst DR, Race RE. Comparative analysis of scrapie agent inactivation methods. J Virol Methods 1993;41:193-201.
282. Race RE, Raymond GJ. Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. J Virol 2004;78:2164-2165.
283. Lemmer K, Mielke M, Pauli G, et al. Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. J Gen Virol 2004;85:3805-3816.
284. Laboratory Safety and Waste Disposal Committee and Pathology Committee. Best management practices for handling suspect biosafety level 2 animal transmissible spongiform encephalopathy (TSE) diagnostic samples (scrapie, chronic wasting disease and transmissible encephalopathy) in animal health laboratories. Davis, Calif: American Association of Veterinary Laboratory Diagnosticians, 2005. Available at: data.memberclicks.com/site/aavld/Best- Management-TSE.pdf. Accessed Nov 30, 2008.
285. World Health Organization. WHO infection control guidelines for transmissible spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland, 23-26 March 1999. WHO/CDS/CSR/APH/2000/3. Geneva: World Health Organization, 2000. Available at: www.who.int/csr/resources/publications/bse/ whocdscsraph2003.pdf. Accessed Nov 30, 2008.